RTI Surgical Launches New Spinal Fusion System

RTI Surgical Inc., has rolled out its Streamline OCT system, which is designed to promote fusion of the occipto-cervico-thoracic spine (or occiput-T3). The company received 510(k) clearance from the U.S. Food and Drug Administration for the system in March and has had a limited release since then.
The Streamline system is intended for use in the treatment of spinal stenosis, tumors, degenerative disc disease and spondylolisthesis. It is designed to allow a rigid construct to be created from occiput to T3 by offering a range of implants, according to the company.

“The Streamline OCT system is another exciting addition to our spine portfolio,” said Brian K. Hutchison, RTI Surgical president and CEO. “We are proud to have a system that offers a range of implants where surgeons can tailor treatment for their patients and provide a more streamlined surgical experience.”

Company officials claim the system is the first to offer a high-angle pedicle screw capable of achieving 60 degrees of angulation in any direction, providing greater intra-operative flexibility and options for screw placement. Streamline OCT also offers a unique occipital plate design that reduces the need for extreme rod bends.

Anthony Lapinsky, M.D., board-certified orthopedic surgeon at Premier Orthopaedics and Sports Medicine in Bloomfield, N.J., and a fellow with the American Academy of Orthopaedic Surgeons, is one of the design surgeons for the system.

“The Streamline OCT system, with its unsurpassed modularity, ensures I can manage the variety of clinical challenges I come across in my practice,” Lapinsky said. “This is due, in large part, to a number of unique implant options, including the highest angle screw on the market.”

Alachua, Fla.-based RTI Surgical makes biologic, metal and synthetic implants used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. It is accredited in the United States by the American Association of Tissue Banks.